Abstract
Again no device was seen ( Figure 2 ). The consultant gynaecologist discussed the findings with the patient. She was able to remember a time some weeks prior to admission when she had experienced severe backache and colicky pain. The consultant hypothesised that the device may have eroded into the bowel and been excreted.
Discussion
Uterine perforation is a rare but well described hazard of insertion of intra-uterine devices, with a perforation rate of 1.3/1000 insertions reported in large clinical studies. 1 Perforation is associated with early post partum insertion, 2 the skill of the inserter, 3 and potentially with undetected pre-existing uterine pathology. 4 It has been postulated that in some women myometrial thickness may be decreased predisposing to perforation during insertion of an anchored device. 5 Use of ultrasound to assess myometrial thickness group.bmj.com on June 18, 2017 -Published by http://jfprhc.bmj.com/ Downloaded from in women prior to GyneFix insertion has been described, 4 but would make this method unpractical in general practice or family planning clinics. Supervised training in insertion procedures and maintenance of clinical skills are prerequisites for safe practice and the Faculty of Family Planning has mechanisms in place to ensure high standards. 6 The GyneFix inserter has been designed following studies of myometrial thickness to minimise any risk of primary perforation, even in women with a myometrial thickness at the lower end of the normal range. 4 Some insertion-related perforations, however, have been reported since its introduction in Europe. In a recent publication, uterine perforation causing acute abdominal pain at insertion followed by ongoing pain was described. The implant was found embedded in the mesorectum and an abscess had formed necessitating laparotomy for removal. 7 This is in keeping with reports of 'lost' conventional IUDs, which have been commonly found completely or partially embedded in other intra-abdominal structures. 8 The plastic frames of conventional devices do not lend themselves to complete penetration of other structures and can therefore cause substantial damage and discomfort to women.
In our case perforation at the time of insertion cannot be excluded, although the patient did not complain of undue pain or discomfort immediately after the procedure. This would explain the presence of the implant in the peritoneal cavity proven by pelvic X-ray 6 weeks post insertion. It does not, however, explain the complete absence of the device at laparoscopy and X-ray 3 months later. It was therefore assumed that there was some kind of predisposition to perforation. Procedures had been carried out by experienced operators, yet the uterus was penetrated twice in a high fundal position and the device was lost without trace, possibly by way of a perforation through the bowel wall and expulsion via the intestinal route.
Clinicians require a high level of suspicion when women attend with complaints soon after insertion of IUDs and IUIs, and a low threshold for initiating further investigations when threads can not be found on clinical examination is appropriate. Women should be advised of the possibility of perforation or expulsion prior to IUD/IUI insertion. They need to be taught to feel for their thread to confirm presence of the device and to attend for a check up in the event that they cannot feel their thread anymore while using an alternative method of contraception.
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